An Ontario man battling Stage 4 melanoma is seeking answers after his request for out-of-country cancer treatment coverage is denied, while continuing to receive therapy through an early-stage trial in Canada. Alex Shved, 37, says the medication from the trial is working and he hopes it will help target his metastatic disease. Global News reports his cancer has been progressing despite other treatments, and his oncologist identifies tumour-infiltrating lymphocyte (TIL) therapy as a potential option. CityNews Toronto says Shved believes he cannot afford to wait for alternatives and is pursuing the issue with Canada’s health-care bureaucracy. Winnipeg Free Press frames his efforts as “two fronts”: treating his advanced cancer and contesting the coverage decision for treatment outside the country. The reports describe Shved as actively trying to obtain access to a specific therapy recommended by his oncologist, amid concerns that the denial may delay care.